Published online before print July 19, 2007

This Article Full Text Full Text (PDF) All Versions of this Article: ajpath.2007.070166v1 171/3/715    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Markiewski, M. M. Articles by Lambris, J. D. Search for Related Content PubMed PubMed Citation Articles by Markiewski, M. M. Articles by Lambris, J. D.

(American Journal of Pathology. 2007;171:715-727.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.070166

Biological Perspectives

The Role of Complement in Inflammatory Diseases From Behind the Scenes into the Spotlight

From the Department of Pathology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

Abstract

Our understanding of the biology of the complement system has undergone a drastic metamorphosis since its original discovery. This system, which was traditionally primarily described as a "complement" to humoral immunity, is now perceived as a central constituent of innate immunity, defending the host against pathogens, coordinating various events during inflammation, and bridging innate and adaptive immune responses. Complement is an assembly of proteins found in the blood and body fluids and on cell surfaces. Soluble complement components form the proteolytic cascade, whose activation leads to the generation of complement effectors that target various cells involved in the immune response. Membrane-bound receptors and regulators transmit signals from complement effectors to target cells and limit complement activation to the surfaces of pathogens and damaged or activated host cells. The multiple interconnections among complement proteins, immune cells, and mediators provide an excellent mechanism to protect the organism against infections and support the repair of damaged tissues. However, disturbances in this "defense machinery" contribute to the pathogenesis of various diseases. The role of complement in various inflammatory disorders is multifaceted; for example, the activation of complement can significantly contribute to inflammation-mediated tissue damage, whereas inherited or acquired complement deficiencies highly favor the development of autoimmunity.

This article has been cited by other articles:

				D. Orth, A. B. Khan, A. Naim, K. Grif, J. Brockmeyer, H. Karch, M. Joannidis, S. J. Clark, A. J. Day, S. Fidanzi, et al. Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome J. Immunol., May 15, 2009; 182(10): 6394 - 6400. [Abstract] [Full Text] [PDF]

				E. Peerschke, W Yin, D. Alpert, R. Roubey, J. Salmon, and B Ghebrehiwet Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies Lupus, May 1, 2009; 18(6): 530 - 538. [Abstract] [PDF]

				M. M. Markiewski, R. A. DeAngelis, C. W. Strey, P. G. Foukas, C. Gerard, N. Gerard, R. A. Wetsel, and J. D. Lambris The Regulation of Liver Cell Survival by Complement J. Immunol., May 1, 2009; 182(9): 5412 - 5418. [Abstract] [Full Text] [PDF]

				S. Ostrand-Rosenberg and P. Sinha Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer J. Immunol., April 15, 2009; 182(8): 4499 - 4506. [Abstract] [Full Text] [PDF]

				P. Baruah, I. E. Dumitriu, T. H. Malik, H. T. Cook, J. Dyson, D. Scott, E. Simpson, and M. Botto C1q enhances IFN-{gamma} production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells Blood, April 9, 2009; 113(15): 3485 - 3493. [Abstract] [Full Text] [PDF]

				M. B. Pagano, H.-f. Zhou, T. L. Ennis, X. Wu, J. D. Lambris, J. P. Atkinson, R. W. Thompson, D. E. Hourcade, and C. T.N. Pham Complement-Dependent Neutrophil Recruitment Is Critical for the Development of Elastase-Induced Abdominal Aortic Aneurysm Circulation, April 7, 2009; 119(13): 1805 - 1813. [Abstract] [Full Text] [PDF]

				P. GERGELY Jr, B. PAZAR, Z. B. NAGY, T. GOMBOS, K. RAJCZY, Z. BALOGH, I. ORBAN, K. SEVCIC, and G. POOR Structural Polymorphisms in the Mannose-Binding Lectin Gene Are Associated with Juvenile Idiopathic Arthritis J Rheumatol, April 1, 2009; 36(4): 843 - 847. [Abstract] [Full Text] [PDF]

				S. Thiel, M. Kolev, S. Degn, R. Steffensen, A. G. Hansen, M. Ruseva, and J. C. Jensenius Polymorphisms in Mannan-Binding Lectin (MBL)-Associated Serine Protease 2 Affect Stability, Binding to MBL, and Enzymatic Activity J. Immunol., March 1, 2009; 182(5): 2939 - 2947. [Abstract] [Full Text] [PDF]

				K. Papp, P. Vegh, K. Miklos, J. Nemeth, K. Rasky, F. Peterfy, A. Erdei, and J. Prechl Detection of Complement Activation on Antigen Microarrays Generates Functional Antibody Profiles and Helps Characterization of Disease-Associated Changes of the Antibody Repertoire J. Immunol., December 1, 2008; 181(11): 8162 - 8169. [Abstract] [Full Text] [PDF]

				G Girardi and N Mackman Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule Lupus, October 1, 2008; 17(10): 931 - 936. [Abstract] [PDF]

				R. F. Savaris, A. E. Hamilton, B. A. Lessey, and L. C. Giudice Endometrial Gene Expression in Early Pregnancy: Lessons From Human Ectopic Pregnancy Reproductive Sciences, October 1, 2008; 15(8): 797 - 816. [Abstract] [PDF]

				K. Kambas, M. M. Markiewski, I. A. Pneumatikos, S. S. Rafail, V. Theodorou, D. Konstantonis, I. Kourtzelis, M. N. Doumas, P. Magotti, R. A. DeAngelis, et al. C5a and TNF-{alpha} Up-Regulate the Expression of Tissue Factor in Intra-Alveolar Neutrophils of Patients with the Acute Respiratory Distress Syndrome J. Immunol., June 1, 2008; 180(11): 7368 - 7375. [Abstract] [Full Text] [PDF]

				H. C. Lehmann and H.-P. Hartung Complementing the therapeutic armamentarium for Miller Fisher Syndrome and related immune neuropathies Brain, May 1, 2008; 131(5): 1168 - 1170. [Full Text] [PDF]